Data as of:
brimindinvest.com / compare / ms-vs-gsLIVE
MS
Morgan Stanley · Financials
$202.58
-5.44% this month
VERSUS
COMPARE
GS
The Goldman Sachs Group, Inc. · Financials
$942.00
-7.80% this month
Comparison scoreboard
GS LEADS 4/5
AI Scorei
MS 65.2
GS 66.0
1Y Returni
MS +27.22%
GS +17.12%
Fwd P/Ei
MS 15.75
GS 13.97
Target Up.i
MS +10.17%
GS +10.41%
Op. Margini
MS 41.57%
GS 42.18%
Metrics last refreshed: 9/20/2026
Quick take

MS vs GS Stock Comparison: AI Score, Valuation, Performance and Upside

ShareXLinkedInRedditFacebookWhatsApp

Morgan Stanley and Goldman Sachs are the two elite capital markets firms but have pursued meaningfully different strategies in recent years. Morgan Stanley has deliberately built wealth management into a durable earnings engine, while Goldman Sachs remains more purely exposed to trading and investment banking cycles. MS offers more earnings stability; GS offers more cyclical upside in bull markets for M&A and capital markets activity.

The core choice is between Morgan Stanley's more stable, wealth-management-weighted business model versus Goldman Sachs's higher-beta exposure to capital markets cycles — investors who believe M&A activity is recovering favor GS; those who want smoother earnings compounding favor MS.

Live analysis · updated 9/20/2026

GS holds the edge across 4 of 5 key metrics in this comparison. MS has delivered stronger 1-year price return (+27.22% vs +17.12%), though GS has the better forward P/E setup (13.97x vs 15.75x for MS). GS leads on both revenue growth (42.50%) and operating margin (42.18%), suggesting a stronger fundamental setup on both dimensions. Analyst consensus implies similar upside for both: +10.17% for MS and +10.41% for GS.

Want a full valuation workup? 46-section report — AI Score, Monte Carlo forecast, bull/bear case, DCF, and more.
Normalized 1Y performance
MS
GS
Recent returns
MS
GS
Analyst price targets & sentiment

Human Wall Street analysts' price targets, typically implying a ~12-month view — a separate signal from this site's own AI Prediction Signal further down the page, which is a 5-/30-day machine-learning forecast based on price history alone.

MS · 19 analysts
STRONG BUYHOLDSTRONG SELL
Hold (2.6/5.0)
11 Buy / 13 Hold / 1 Sell
Price target range
analyst low$101.00
analyst mean$236.62
current price$202.58
+10.2% upside to analyst mean
GS · 19 analysts
STRONG BUYHOLDSTRONG SELL
Buy (2.5/5.0)
7 Buy / 16 Hold / 2 Sell
Price target range
analyst low$490.00
analyst mean$1,141.65
current price$942.00
+10.4% upside to analyst mean
Who should consider this stock?
MS may suit investors who:
  • prefer financial services with significant wealth management recurring revenue reducing earnings cyclicality
  • value the integrated firm model combining institutional and retail client relationships
  • want dividend growth and buyback capacity supported by stable fee-based income
  • are comfortable with equity market sensitivity as wealth AUM affects fee revenue
GS may suit investors who:
  • want maximum exposure to a recovering M&A and capital markets cycle
  • believe Goldman's franchise position in advisory and trading generates superior market-share revenue
  • are willing to accept higher earnings cyclicality for potentially higher peak earnings
  • value the strategic clarity of returning to Goldman's institutional core competencies
Performance & AI score
Performance & AI score
MetricMSGS
AI scorei65.266.0
AI ranki#79#71
Latest closei$202.58$942.00
1M returni-5.44%-7.80%
6M returni+27.77%+16.37%
1Y returni+27.22%+17.12%
$10,000 invested — hypothetical growth (dividends reinvested)

How much would $10,000 be worth today if invested at the start of each period, with all dividends reinvested?

$10,000 invested — hypothetical growth (dividends reinvested)
PeriodMSGS
1Y ago$12.72K (+27.2%)
started 2025-09-18
$11.71K (+17.1%)
started 2025-09-18
5Y ago$26.82K (+168.2%)
started 2021-09-20
$30.03K (+200.3%)
started 2021-09-20
10Y ago$109.51K (+995.1%)
started 2016-09-19
$82.06K (+720.6%)
started 2016-09-19

Hypothetical — past performance does not guarantee future results.

Valuation & upside potential
Valuation & upside potential
MetricMSGS
Market capi$337.31B$301.07B
Trailing P/Ei17.3616.08
Forward P/Ei15.7513.97
Price/Salesi3.313.55
EV/Revenuei2.781.00
Analyst targeti$236.62$1,141.65
Target upsidei+10.17%+10.41%
Growth, profitability & risk
Growth, profitability & risk
MetricMSGS
Revenue growthi28.00%42.50%
Earnings growthi62.40%92.30%
EPS growthi+62.40%+92.30%
FCF marginiN/AN/A
Operating margini41.57%42.18%
Profit margini25.90%31.04%
ROIC proxyi17.97%16.90%
Return on equityi17.97%16.90%
Dividend yieldi2.14%1.92%
Payout ratioi32.31%26.25%
Dividend growth streakiNo increase yetNo increase yet
Betai1.211.29
Debt/equityi517.28725.38
Current ratioi2.001.56
Quick ratioi1.601.41
Correlation

Over the past year, MS and GS have moved strongly in the same direction (correlation of 0.85), based on daily returns.

1Y
0.85
-1.0+1.0
5Y
0.84
-1.0+1.0
10Y
0.86
-1.0+1.0
Drawdown & downside risk

Lower drawdown and smaller single-period drops generally indicate a smoother ride, though they do not guarantee lower future risk.

1Y risk snapshot
MS max drawdowni19.28%
GS max drawdowni19.84%
MS max wkly dropi8.42%
GS max wkly dropi10.69%
5Y risk snapshot
MS max drawdowni32.38%
GS max drawdowni32.84%
MS max wkly dropi13.51%
GS max wkly dropi15.72%
10Y risk snapshot
MS max drawdowni51.33%
GS max drawdowni48.75%
MS max wkly dropi26.49%
GS max wkly dropi24.20%
Performance metrics by period
Performance metrics by period
PeriodMetricMSGS
1YGrowthi+27.22%+17.12%
CAGRi+27.24%+17.13%
Volatilityi28.18%31.96%
Sharpe ratioi0.840.52
Sortino ratioi1.210.75
Max drawdowni19.28%19.84%
Current drawdowni11.36%18.23%
Avg drawdowni4.66%5.95%
Ulcer Indexi6.63%7.69%
Max daily dropi6.19%7.47%
Max wkly dropi8.42%10.69%
5YGrowthi+133.88%+172.96%
CAGRi+18.54%+22.27%
Volatilityi28.91%28.73%
Sharpe ratioi0.580.69
Sortino ratioi0.841.02
Max drawdowni32.38%32.84%
Current drawdowni11.36%18.23%
Avg drawdowni10.62%10.40%
Ulcer Indexi13.58%13.54%
Max daily dropi9.51%9.21%
Max wkly dropi13.51%15.72%
10YGrowthi+724.80%+576.51%
CAGRi+23.50%+21.07%
Volatilityi31.41%30.17%
Sharpe ratioi0.690.64
Sortino ratioi1.020.94
Max drawdowni51.33%48.75%
Current drawdowni11.36%18.23%
Avg drawdowni11.01%12.11%
Ulcer Indexi14.59%15.59%
Max daily dropi15.60%12.71%
Max wkly dropi26.49%24.20%
AI Prediction Signali
Members only
Next 5 trading days
MS
+2.8%BUY
GS
+1.1%HOLD
Next 30 trading days
MS
+6.4%BUY
GS
+3.2%HOLD

Sign up to unlock AI price predictions

ML model trained on historical prices · 14-day free trial · No credit card required
Business comparison
Business comparison
CategoryMSGS
CompanyMorgan StanleyThe Goldman Sachs Group, Inc.
SectorFinancial ServicesFinancial Services
IndustryCapital MarketsCapital Markets
Core businessMorgan Stanley has deliberately transformed its business mix over the past decade, growing wealth management (through acquisitions of E*Trade and Eaton Vance) to the point where it now generates over 40% of revenue. The Integrated Firm model — offering investment banking, trading, and wealth management to the same clients — is the core competitive advantage. Fee-based recurring revenue from wealth and investment management provides earnings stability that pure-play investment banks cannot match.Goldman Sachs is the premier global investment bank and markets trading firm, consistently ranked #1 in M&A advisory and equity underwriting globally. Its business segments include Global Banking & Markets (investment banking and trading), Asset & Wealth Management (institutional asset management and private wealth), and Platform Solutions (consumer financial products). Goldman is refocusing on its core institutional strengths after retreating from consumer banking (Marcus) which generated significant losses.
Investor focusInvestors track wealth management net new assets, fee-based asset management revenue growth, the progression of institutional equities trading market share, and the return on equity trajectory as the revenue mix shifts further toward fee-based businesses.Investors track investment banking and trading revenue cyclicality, the M&A advisory backlog as a leading indicator, Asset & Wealth Management fee revenue growth, and ROE recovery from the Marcus write-downs.
MS strengths
  • Wealth management segment generates over $7B in pre-tax profit providing earnings floor stability
  • E*Trade integration brought 8M+ retail brokerage accounts deepening the wealth funnel
  • Consistently higher ROE than most peers due to the fee-based business mix
GS strengths
  • Unrivaled franchise in M&A advisory and equity capital markets globally
  • Fixed income and equities trading generate outsized market share revenue in volatile markets
  • Strategic exit from consumer banking reduces loss-making drag and refocuses capital allocation
Risks to watch — MS
  • Wealth management revenue sensitive to equity market levels and financial advisor attrition
  • Investment banking cycle recovery timing affecting capital markets revenue
  • Integration execution risk from multiple large acquisitions
Risks to watch — GS
  • Heavy dependence on capital markets activity (M&A, IPO volume) creates cyclical earnings volatility
  • Marcus consumer banking exit involved multi-billion dollar write-downs and reputational costs
  • Less fee-based recurring revenue than Morgan Stanley means less earnings stability
Frequently asked questions
Morgan Stanley's earnings are more stable and predictable due to wealth management's recurring revenue, making it the better choice for investors who want lower cyclicality. Goldman Sachs has higher leverage to an investment banking recovery cycle and may outperform significantly when M&A volumes rebound. The better choice depends on where we are in the market cycle — in recovery, GS tends to outperform; in a downturn, MS holds up better.
Free public comparison

Want deeper AI forecasts?

This comparison page is public and free forever. Subscribers can unlock saved watchlists, full AI rankings, detailed forecasts, and interactive analysis tools.

In-Depth Reports

Full valuation workup with AI Score, Monte Carlo forecast, and bull/bear case — free preview, premium data from $3.99.

Related comparisons
More comparisons
Browse all 1,000 comparisons
ShareXLinkedInRedditFacebookWhatsApp